相关实验视频

Updated: Jan 15, 2026

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

使用BMP-2-转化介质干细胞与免疫抑制相结合的全基因基因疗法可增强骨愈合

Jacob R Ball¹, Matthew C Gallo¹, Julian Wier¹

¹Department of Orthopaedic Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.

Molecular therapy : the journal of the American Society of Gene Therapy

|October 15, 2025

概括

暂时的免疫抑制显著增强了所有基因脂肪衍生干细胞 (ADSCs) 基因疗法用于骨再生. 这种方法显示出开发一种"现成"治疗关键大小骨缺陷的前景.

科学领域:

再生医学是一种再生医学.
生物材料科学生物材料科学
免疫学免疫学免疫学

背景情况:

关键大小的骨缺陷是一个重大的临床挑战.
目前对骨再生的治疗选择有限.
基于细胞的全基因疗法具有潜力,但面临免疫学障碍.

研究的目的:

为了评估所有基性脂肪衍生干细胞 (ADSCs) 的疗效,这些干细胞被设计成表达骨形态遗传蛋白-2 (BMP-2),用于治疗大小关键的大腿缺陷.
确定临时FK506 (塔克罗利斯) 免疫抑制对BMP-2-转ADSCs治疗结果的影响.

主要方法:

路易斯大鼠有6毫米的腹腔半骨缺陷,接受了BMP-2-转或非转的全基ADSCs,有或没有FK506治疗.
骨愈合被评估在12周使用生物力学测试,放射学,组织学和微型计算机断层扫描 (微型CT).
试验室试验评估了FK506对BMP-2产生和骨质分化的影响.

主要成果:

接受BMP-2转化ADSCs的免疫抑制小鼠表现出显著增强的骨愈合,由更高的扭曲硬度,峰值扭矩和能量到失败证明.
放射性,组织学和微型CT分析证实,在用BMP-2ADSCs治疗的免疫抑制动物中,新骨的形成较大.
不被转换的ADSCs导致骨愈合最小,不管免疫抑制,FK506没有增强体外骨质生成能力.

结论:

暂时的免疫抑制显著提高了基于细胞的基因疗法对骨再生的有效性.
这一策略克服了免疫障碍,为治疗关键大小骨缺陷的"现成"治疗产品铺平了道路.
在这种情况下,FK506的主要益处似乎是免疫调节,而不是直接增强骨质诱导活性.

关键词:

美国BMP-2战斗机.所有的异构物质都是异构的.骨缺陷是一种骨缺陷.骨再生骨再生基因治疗的基因疗法这是一个lentiviral向量.介质细胞干细胞介质细胞干细胞

更多相关视频

Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts

Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts

Published on: December 22, 2015

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

相关概念视频

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...